Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer: Impact of CDK4/6 Inhibitors on the Current Treatment Paradigm
Asia-Pacific Journal of Clinical Oncology - United Kingdom
doi 10.1111/ajco.13064
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Wiley